Trial Profile
AZE/FLU Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Azelastine/fluticasone-propionate (Primary)
- Indications Allergic rhinitis; Seasonal allergic rhinitis
- Focus Therapeutic Use
- 05 Dec 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Dec 2015).
- 09 Nov 2017 Results (n=28) published in the Allergy
- 09 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov